Remembering a Great Friend to the LRG – Chuck Korte
To so many in our community, Chuck was a beacon of hope. He was one of the very few long-term survivors from the original Gleevec (STI-571) clinical trial, which he joined in 2001. For [...]
To so many in our community, Chuck was a beacon of hope. He was one of the very few long-term survivors from the original Gleevec (STI-571) clinical trial, which he joined in 2001. For [...]
Chuck Korte presented his story as Long-term GIST Survivor at New Horizons 2021.
For GIST patients, long term survival is the ultimate goal. A number of factors may influence long term survival β some of these are demographic and clinical, like mutational subtype and genetic factors. However, there are a number of others that are perhaps more subtle, such as lifestyle, attitude, and access to treatment, experts, and advice.